These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23456500)
1. MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer. Dong W; Wang L; Shen R Dig Dis Sci; 2013 Jul; 58(7):2038-45. PubMed ID: 23456500 [TBL] [Abstract][Full Text] [Related]
2. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. Meng CF; Zhu XJ; Peng G; Dai DQ World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of MYO5B promotes invasion and motility in gastric cancer cells. Dong W; Chen X; Chen P; Yue D; Zhu L; Fan Q Dig Dis Sci; 2012 May; 57(5):1247-52. PubMed ID: 22134786 [TBL] [Abstract][Full Text] [Related]
4. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
6. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752 [TBL] [Abstract][Full Text] [Related]
7. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
8. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. Jee CD; Kim MA; Jung EJ; Kim J; Kim WH Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878 [TBL] [Abstract][Full Text] [Related]
9. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker. Raja UM; Gopal G; Rajkumar T Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218 [TBL] [Abstract][Full Text] [Related]
10. Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Yun J; Song SH; Park J; Kim HP; Yoon YK; Lee KH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY Lab Invest; 2012 Jul; 92(7):1033-44. PubMed ID: 22508389 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468 [TBL] [Abstract][Full Text] [Related]
12. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554 [TBL] [Abstract][Full Text] [Related]
13. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682 [TBL] [Abstract][Full Text] [Related]
16. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
17. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142 [TBL] [Abstract][Full Text] [Related]
18. The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance. Zhu X; Liu J; Xu X; Zhang C; Dai D Int J Oncol; 2015 Jan; 46(1):195-204. PubMed ID: 25355626 [TBL] [Abstract][Full Text] [Related]
19. Human ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer. Song IS; Ha GH; Kim JM; Jeong SY; Lee HC; Kim YS; Kim YJ; Kwon TK; Kim NS Int J Cancer; 2011 Nov; 129(9):2124-33. PubMed ID: 21170990 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer. Dong W; Chen X; Xie J; Sun P; Wu Y Int J Cancer; 2010 Oct; 127(7):1526-34. PubMed ID: 20063316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]